{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:53:03Z","timestamp":1753890783535,"version":"3.41.2"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T00:00:00Z","timestamp":1652659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Aim<\/jats:title><jats:p>We aimed to investigate the association between obesity-related parameters and polyneuropathy (PN) and to evaluate inflammatory and fibrotic gene expression of fat as a potential mediator in subjects scheduled to undergo metabolic bariatric surgery (MBS).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This was a cross-sectional study of MBS cohort. Body composition and visceral fat area (VFA) were quantified by bioimpedance analysis and computed tomography scan. PN was defined by Michigan Neuropathy Screening Instrument\u2013Physical Examination score was &amp;gt; 2. We measured mRNA expression level of <jats:italic>FN1<\/jats:italic>, <jats:italic>TIMP1<\/jats:italic>, <jats:italic>CCL2<\/jats:italic>, and <jats:italic>CXCL8<\/jats:italic> in omental fat tissue.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of 189 subjects (mean age, 39.4 years; 69 [36.5%] male; mean body mass index, 38.5 kg\/m<jats:sup>2<\/jats:sup>), prevalence of PN was 9.1% in subjects without diabetes (n = 110) and 20.3% in those with diabetes (n = 79). Nondiabetic subjects with PN had higher homeostatic model assessment-insulin resistance (6.8 \u00b1 3.5 <jats:italic>vs<\/jats:italic> 4.5 \u00b1 2.8, <jats:italic>p<\/jats:italic> = 0.041), and increased fat mass (58.5 \u00b1 12.5 kg <jats:italic>vs<\/jats:italic> 50.5 \u00b1 10.7 kg, <jats:italic>p<\/jats:italic> = 0.034), and VFA (309.4 \u00b1 117.6 cm<jats:sup>2<\/jats:sup><jats:italic>vs<\/jats:italic> 243.5 \u00b1 94.2 cm<jats:sup>2<\/jats:sup>, <jats:italic>p<\/jats:italic> = 0.046) compared to those without PN. These obesity-related parameters were significantly associated with the presence of PN after adjusting for conventional risk factors of PN only in subjects without diabetes. In contrast, a fibrotic gene such as <jats:italic>TIMP1<\/jats:italic> was independently associated with PN (adjusted odds ratio of 1.56; 95% confidence interval 1.06, 2.30) only in subjects with diabetes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Increased adiposity was independently associated with PN in obese subjects without diabetes. In contrast, this association was not significant after adjusting conventional risk factors of PN in obese subjects with diabetes but increased fibrotic gene expression in fat was associated with PN in this group.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2022.881093","type":"journal-article","created":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T06:02:01Z","timestamp":1652680921000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Association Between Fat Mass or Fat Fibrotic Gene Expression and Polyneuropathy in Subjects With Obesity: A Korean Metabolic Bariatric Surgery Cohort"],"prefix":"10.3389","volume":"13","author":[{"given":"Kyuho","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tae Jung","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Suk","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Won","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyen Chung","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jihye","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun Kyung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Hee","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hak Chul","family":"Jang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.20.7.1162","article-title":"Risk Factors for Diabetic Peripheral Sensory Neuropathy. Results of the Seattle Prospective Diabetic Foot Study","volume":"20","author":"Adler","year":"1997","journal-title":"Diabetes Care"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00929","article-title":"New Perspective in Diabetic Neuropathy: From the Periphery to the Brain, A Call for Early Detection, and Precision Medicine","volume":"10","author":"Yang","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B3","doi-asserted-by":"publisher","first-page":"CD007543","DOI":"10.1002\/14651858.CD007543.pub2","article-title":"Enhanced Glucose Control for Preventing and Treating Diabetic Neuropathy","author":"Callaghan","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.2337\/dc18-1842","article-title":"General and Abdominal Obesity and Incident Distal Sensorimotor Polyneuropathy: Insights Into Inflammatory Biomarkers as Potential Mediators in the Kora F4\/Ff4 Cohort","volume":"42","author":"Schlesinger","year":"2019","journal-title":"Diabetes Care"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.2337\/dc17-2062","article-title":"Risk Factors for Incident Diabetic Polyneuropathy in a Cohort With Screen-Detected Type 2 Diabetes Followed for 13 Years: Addition-Denmark","volume":"41","author":"Andersen","year":"2018","journal-title":"Diabetes Care"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2019.01607","article-title":"Chronic Adipose Tissue Inflammation Linking Obesity to Insulin Resistance and Type 2 Diabetes","volume":"10","author":"Zatterale","year":"2019","journal-title":"Front Physiol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1172\/JCI19451","article-title":"Chronic Inflammation in Fat Plays a Crucial Role in the Development of Obesity-Related Insulin Resistance","volume":"112","author":"Xu","year":"2003","journal-title":"J Clin Invest"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2016.3745","article-title":"Association Between Metabolic Syndrome Components and Polyneuropathy in an Obese Population","volume":"73","author":"Callaghan","year":"2016","journal-title":"JAMA Neurol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"89","DOI":"10.4161\/adip.19752","article-title":"Peri-Adipocyte Ecm Remodeling in Obesity and Adipose Tissue Fibrosis","volume":"1","author":"Chun","year":"2012","journal-title":"Adipocyte"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-011-2093-9","article-title":"Tissue Inhibitor of Matrix Metalloproteinase 1 (Timp1) Controls Adipogenesis in Obesity in Mice and in Humans","volume":"54","author":"Meissburger","year":"2011","journal-title":"Diabetologia"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-0369","article-title":"A Unique Role of Monocyte Chemoattractant Protein 1 Among Chemokines in Adipose Tissue of Obese Subjects","volume":"90","author":"Dahlman","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1186\/1476-9255-6-25","article-title":"Inhibitory Effect of Il-8 on Insulin Action in Human Adipocytes Via Map Kinase Pathway","volume":"6","author":"Kobashi","year":"2009","journal-title":"J Inflammation (Lond)"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.2337\/dc21-S002","article-title":"2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2021","volume":"44","year":"2021","journal-title":"Diabetes Care"},{"key":"B14","doi-asserted-by":"publisher","first-page":"81","DOI":"10.7570\/jomes21022","article-title":"2020 Korean Society for the Study of Obesity Guidelines for the Management of Obesity in Korea","volume":"30","author":"Kim","year":"2021","journal-title":"J Obes Metab Syndr"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-145-4-200608150-00004","article-title":"Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate","volume":"145","author":"Levey","year":"2006","journal-title":"Ann Intern Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/BF00280883","article-title":"Homeostasis Model Assessment: Insulin Resistance and Beta-Cell Function From Fasting Plasma Glucose and Insulin Concentrations in Man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s11695-021-05569-6","article-title":"Comparison of Bioelectrical Impedance Analysis and Computed Tomography on Body Composition Changes Including Visceral Fat After Bariatric Surgery in Asian Patients With Obesity","volume":"31","author":"Lee","year":"2021","journal-title":"Obes Surg"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.17.11.1281","article-title":"A Practical Two-Step Quantitative Clinical and Electrophysiological Assessment for the Diagnosis and Staging of Diabetic Neuropathy","volume":"17","author":"Feldman","year":"1994","journal-title":"Diabetes Care"},{"key":"B19","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1900\/RDS.2015.12.48","article-title":"Risk Factors and Comorbidities in Diabetic Neuropathy: An Update 2015","volume":"12","author":"Papanas","year":"2015","journal-title":"Rev Diabetes Stud"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.2337\/dc16-2042","article-title":"Diabetic Neuropathy: A Position Statement by the American Diabetes Association","volume":"40","author":"Pop-Busui","year":"2017","journal-title":"Diabetes Care"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60576-4","article-title":"Effect of Intensive Treatment of Hyperglycaemia on Microvascular Outcomes in Type 2 Diabetes: An Analysis of the Accord Randomised Trial","volume":"376","author":"Ismail-Beigi","year":"2010","journal-title":"Lancet"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-0903","article-title":"Prevalence of Neuropathy and Peripheral Arterial Disease and the Impact of Treatment in People With Screen-Detected Type 2 Diabetes: The Addition-Denmark Study","volume":"34","author":"Charles","year":"2011","journal-title":"Diabetes Care"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0808431","article-title":"Glucose Control and Vascular Complications in Veterans With Type 2 Diabetes","volume":"360","author":"Duckworth","year":"2009","journal-title":"N Engl J Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.06-05-01211.1986","article-title":"Effects of Insulin, Insulin-Like Growth Factor-Ii, and Nerve Growth Factor on Neurite Formation and Survival in Cultured Sympathetic and Sensory Neurons","volume":"6","author":"Recio-Pinto","year":"1986","journal-title":"J Neurosci"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.53.7.1824","article-title":"Direct Insulin Signaling of Neurons Reverses Diabetic Neuropathy","volume":"53","author":"Brussee","year":"2004","journal-title":"Diabetes"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2020.100649","article-title":"Proinflammatory Cytokines Predict the Incidence of Diabetic Peripheral Neuropathy Over 5 Years in Chinese Type 2 Diabetes Patients: A Prospective Cohort Study","volume":"31","author":"Zheng","year":"2021","journal-title":"EClinicalMedicine"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1177\/14791641211002470","article-title":"Plasma Levels of Tissue Inhibitor of Metalloproteinase-1 in Patients With Type 1 Diabetes Mellitus Associate With Early Diabetic Neuropathy and Nephropathy","volume":"18","author":"Papadopoulou-Marketou","year":"2021","journal-title":"Diabetes Vasc Dis Res"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.881093\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T06:02:03Z","timestamp":1652680923000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.881093\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,16]]},"references-count":27,"alternative-id":["10.3389\/fendo.2022.881093"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.881093","relation":{},"ISSN":["1664-2392"],"issn-type":[{"type":"electronic","value":"1664-2392"}],"subject":[],"published":{"date-parts":[[2022,5,16]]},"article-number":"881093"}}